Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huangjing Yangji Formula Combined With Resistance Training for Sarcopenia
NCT07321535Not yet recruiting
- Sponsor
- 中国中医科学院望京医院
- Start
- Jan 2026
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Sarcopenia comparing Huangjing Yangji Formula + Training with Placebo + Training (2 arms). Primary endpoint: Short Physical Performance Battery at 4 months. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
Huangjing Yangji Formula
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT07321535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07321535.